Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;92(11):2251-2253.
doi: 10.1002/jmv.26047. Epub 2020 Jun 9.

Convalescent plasma therapy: A passive therapy for an aggressive COVID-19

Kamal Kant Sahu  1 , Vishal Jindal  2 , Ahmad Daniyal Siddiqui  1 , Jan Cerny  3 , Jonathan M Gerber  3
Affiliations

Convalescent plasma therapy: A passive therapy for an aggressive COVID-19

Kamal Kant Sahu et al. J Med Virol. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

References

    1. Sahu KK, Lal A, Mishra AK. Latest updates on COVID‐2019: a changing paradigm shift. J Med Virol. 2020;92:533‐535. - PMC - PubMed
    1. Sahu KK, Mishra AK, Lal A. Covid‐2019: update on epidemiology, disease spread and management [published online ahead of print April 16, 2020]. Monaldi Arch Chest Dis. 2020;90(1). 10.4081/monaldi.2020.1292 - DOI - PubMed
    1. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID‐19. J Clini Invest Am Soc Clin Invest. 2020;130:1545‐1548. - PMC - PubMed
    1. Soo YOY, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10(7):676‐678. - PMC - PubMed
    1. Cheng Y, Wong R, Soo YOY, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24(1):44‐46. - PMC - PubMed